Ignite Creation Date:
2025-12-25 @ 12:55 AM
Ignite Modification Date:
2025-12-25 @ 11:10 PM
Study NCT ID:
NCT05446467
Status:
RECRUITING
Last Update Posted:
2025-08-20
First Post:
2022-06-30
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Pembrolizumab in Combination With Low-dose PFas Neoadjuvant Treatment for Locally Advanced HNSCC
Sponsor:
Zhejiang Provincial People's Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-09-01
Start Date Type:
ACTUAL
Primary Completion Date:
2026-03-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-06-01
Completion Date Type:
ESTIMATED
First Submit Date:
2022-06-30
First Submit QC Date:
None
Study First Post Date:
2022-07-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-14
Last Update Post Date:
2025-08-20
Last Update Post Date Type:
ACTUAL